- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 317/12 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 317/12
Total number of patents in this class: 107
10-year publication summary
|
7
|
5
|
5
|
7
|
3
|
8
|
10
|
5
|
3
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Eastman Chemical Company | 2208 |
10 |
| Firmenich SA | 1701 |
8 |
| BASF SE | 21039 |
5 |
| DSM IP Assets B.V. | 5575 |
4 |
| Kolon Plastics, Inc. | 62 |
4 |
| Segetis, Inc. | 39 |
4 |
| V. Mane Fils | 162 |
4 |
| Shell Internationale Research Maatschappij B.V. | 3557 |
3 |
| Council of Scientific & Industrial Research | 1438 |
3 |
| Vertex Pharmaceuticals Incorporated | 1626 |
2 |
| ENI S.p.A. | 1274 |
2 |
| Gilead Sciences, Inc. | 2060 |
2 |
| Ishihara Sangyo Kaisha, Ltd. | 662 |
2 |
| Kuraray Co., Ltd. | 3522 |
2 |
| University of Newcastle upon Tyne | 245 |
2 |
| ADT Pharmaceuticals, LLC | 13 |
2 |
| The Procter & Gamble Company | 22003 |
1 |
| Bristol-myers Squibb Company | 4850 |
1 |
| F. Hoffmann-La Roche AG | 7947 |
1 |
| Merck Patent GmbH | 5773 |
1 |
| Other owners | 44 |